Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
EVP Research
-
Stock Symbol
-
IONS on Nasdaq
Eric Swayze - trading volume in the past year for Ionis Pharmaceuticals Inc
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Restricted Stock Unit |
46.7K |
$2.36M |
$50.42 |
Jan 16, 2024 |
Direct |
Common Stock |
|
Performance Restricted Stock Units |
42.5K |
$2.13M |
$50.19 |
Jan 15, 2024 |
Direct |
Common Stock |
|
Common Stock |
33.7K |
$1.28M |
$37.92 |
Nov 12, 2024 |
Direct |
|
|
Restricted Stock Unit |
551 |
$27.8K |
$50.42 |
Jan 16, 2024 |
by Son |
Common Stock |
|
Restricted Stock Unit |
426 |
$16.3K |
$38.31 |
Oct 15, 2024 |
by Son |
Common Stock |
|
Common Stock |
157 |
$5.95K |
$37.92 |
Nov 12, 2024 |
by Son |
|
|
Non-Qualified Stock Option (right to buy) |
27.2K |
|
|
Jan 2, 2024 |
Direct |
Common Stock |
|
Non-Qualified Stock Option (right to buy) |
154 |
|
|
Jan 2, 2024 |
by Son |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.